Management and Treatment of Recurrent Epithelial Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management and Treatment of Recurrent Epithelial Ovarian Cancer

Published:2018-12 Issue:6 Volume:32 Page:965-982
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Armbruster Shannon,Coleman Robert L.,Rauh-Hain Jose Alejandro

Funder

Clovis

AstraZeneca

Janssen

Merck

Roche

Genentech

Genmab

Tesaro

Abbvie

Easai

CPRIT

the Ann Rife Cox Chair in Gynecology

Judy Reis

Albert Pisani

MD Anderson ovarian cancer research fund

American Association of Obstetricians and Gynecologists Foundation

NIH

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference69 articles.

1. Timing isn’t everything: an analysis of when to start salvage chemotherapy in ovarian cancer;McMeekin;Gynecol Oncol,2004

2. Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature;Gadducci;Crit Rev Oncol Hematol,2005

3. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991

4. Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design;Markman;J Clin Oncol,2004

5. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial;Parmar;Lancet,2003

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway;Apoptosis;2023-12-12

2. Function of m ⁵ C RNA methyltransferase NOP2 in high-grade serous ovarian cancer;Cancer Biology & Therapy;2023-10-06

3. A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer;Journal of Obstetrics and Gynaecology Research;2023-05-25

4. Integrated analysis of ovarian cancer patients from prospective transcription factor activity reveals subtypes of prognostic significance;Heliyon;2023-05

5. ДРУГА ЛІНІЯ ЛІКУВАННЯ РЕЦИДИВУЮЧОГО РАКУ ЯЄЧНИКІВ: ВІД КЛІНІЧНИХ ДОСЛІДЖЕНЬ ДО СУЧАСНИХ ВОЄННИХ РЕАЛІЙ;Grail of Science;2023-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3